NDC product
ACETAMINOPHEN ASPIRIN AND CAFFEINE
NDC 21130-074 · Better Living Brands, LLC
Key facts
| Product NDC | 21130-074 |
|---|---|
| Proprietary name | ACETAMINOPHEN ASPIRIN AND CAFFEINE |
| Nonproprietary name | acetaminophen, aspirin and caffeine |
| Substances | ACETAMINOPHEN, ASPIRIN, CAFFEINE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Better Living Brands, LLC |
| Product type | HUMAN OTC DRUG |
| Marketing category | ANDA |
| Application number | ANDA211695 |
| Pharmacologic classes | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE] and 5 more |
| Marketing start | Aug 11, 2023 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: